Explained: How China’s Public Payer Wants To Define Innovative Drugs

 
• By Dexter Jie Yan
  
define
China's public payer is attempting to define innovation in drug development while capping innovative drug prices. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia